HealthEU-Startupsabout 2 hours ago
VectorY Therapeutics Raises €74.5 Million
3 min read
Amsterdam-based VectorY Therapeutics raised €74.5 million ($83.5 million) in new financing to advance its pipeline for neurodegenerative diseases. Investors include Angelini Ventures, Invest-NL, and the European Investment Bank. The funds will support the PIONEER-ALS Phase 1/2 clinical study and development of VTx-003 for Huntington's disease.
Level
Hype check
Tap to vote and see what everyone thinks.